Latest National Institute for Health and Clinical Excellence Stories
By Lyndsay Moss Health Correspondent DENYING patients free treatment because they choose to pay for drugs not available on the NHS is inhumane, the leader of Scotland's doctors says.
By Kate Foster; Louisa Pearson MARY DUNN remembers only too well what nursing was like in Scotland in the early days of the NHS: diphtheria and tuberculosis, long shifts and hours spent shining the floors.
The National Health Service is said to be in quandary over its practice of excluding patients who seek private treatment, especially for cancer, according to Financial Times.
A controversial weight-loss drug has been approved for use on the NHS, it was announced today. Rimonabant will be made available to overweight or obese patients who cannot take, or who have had no success with, two other drugs, orlistat and sibutramine.
The National Institute for Health and Clinical Excellence has recommended adalimumab as a treatment option for adults with severe chronic plaque psoriasis.
By John Rentoul Old Labour practices live on in the cruel rule that prevents NHS patients paying for extra cancer treatment Once upon a time, at the very beginning of New Labour, before it was even called New Labour, Neil Kinnock made the speech of his life that would change politics.
Ministers yesterday announced a review of a controversial policy which denies patients NHS treatment if they top up their care privately.
By Jeremy Laurance Health Editor Ministers have bowed to public and political pressure and performed a U-turn over rules denying NHS patients the right to top up their care with treatment paid for privately.
LONDON (Reuters) - Memory clinics and drugs to slow the progress of symptoms of Alzheimer's disease are diverting resources in Britain's state-funded health services from high quality integrated care, doctors said on Friday.
LONDON (Reuters) - Two new targeted therapies for bowel cancer should not be used on Britain's state-run health service, the country's cost-effectiveness watchdog NICE said on Monday.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.